BiovaxID® Personalized Lymphoma Vaccine is Featured in Article Published in …Business Wire (press release)This vaccine, in combination with chemotherapy and rituximab, has the potential to achieve that goal of curing patients.” The article, titled…
Olanzapine drives Dr Reddy's business in third quarterPMLiVEDr Reddy's is also starting to build a portfolio of biosimilars in emerging markets – including arthritis treatment rituximab and filgrastim – which could add $100m in revenues in the …
Rituximab possible treatment option for patients with primary biliary cirrhosisEureka! Science NewsAn open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an …
Rituximab shows promise against primary biliary cirrhosisNews-Medical.netAn open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the…
Rituximab possible treatment option for patients with primary biliary cirrhosisEurekAlert (press release)An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who h…
ME Association Poll: Would you take part in a Rituximab trial?ProHealthMEAssociation.org.uk – scroll to bottom, box on the right) is: “If the MEA Ramsay Research Fund helps to fund a high quality Rituximab trial, would you be willing to take part?”…
Immunomedics Awarded Broad Patent for Anti-CD20 and Anti-CD22 Combination TherapyMarketWatch (press release)We have seen positive results in clinical trials combining our anti-CD22 antibody, epratuzumab, with the anti-CD20 antibody, rituximab. With the…
Proactive Investors USA & CanadaBiogen Idec Surpasses $5 Billion in 2011 Annual RevenueMarketWatch (press release)RITUXAN(R) (rituximab) revenues from our unconsolidated joint business arrangement were $1.0 billion for the year, a decrease of 7% versus…
MedPage TodaySingle Lot of Cancer Drug Pulled for Glass BitsMedPage TodayBendamustine HCL is indicated for treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma that has progressed within six months of treatment with …
Philadelphia Inquirer (blog)Teva's Cephalon recalls 1 lot of injectable leukemia drug TreandaPhiladelphia Inquirer (blog)The drug is approved for the treatment of patients with "indolent B-cell non-Hodgkin's lymphoma (NHL) that has progres…